Who invested in Frontier Medicines

2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcarePharma

Funding summaryUpdated 26 Oct 2026

$87Mraised across 2 rounds since 2019, from 2 sources

$67MSeries A$20MSeries C

Latest round: Series C, $20MJun 2024
Biggest round: $67MSeries A · Jun 2019
Investors: 5 (3 led)

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20202021202220232024

$67MSeries A$20MSeries C

First round: Series A, $67M
Biggest round: $67M
Between rounds: 4.9 years

The rounds

Jun 2024
Series C$20M3 returning
Source recorded
Jun 2019
Series A$67M5 new
- DeerfieldLead
- MPM CapitalLead
- DROIA Oncology VenturesLead
- DCVC
- RA Capital Management
Reported by FinSMEsSEC filing: $34M sold, first sale Apr 2019

Founders and team

From the SEC filings it signed: 5 on the team.

Chris VarmaExecutive Officer, Directori
Gregory ChowExecutive Officeri
Jim WinklerExecutive Officeri
Johannes HermannExecutive Officeri
Kevin WebsterExecutive Officeri

On the board, as filediCameron WheelerJanwillem NaesensLuke EvninOthman Laraki

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2019Series C2024

DeerfieldL

DCVC

RA Capital Management

MPM CapitalLDROIA Oncology VenturesL

Everyone who backed them

DeerfieldVC firm2rounds, led 1

DCVCVC firm2rounds

RA Capital ManagementPrivate equity2rounds

MPM CapitalPrivate equity1round, led 1

DROIA Oncology VenturesVC firm1round, led 1

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Frontier Medicines as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.